Please enable JavaScript.
Coggle requires JavaScript to display documents.
nanorobots in medical world - Coggle Diagram
nanorobots in medical world
Structure and Technical Mechanisms
2.2 Propulsion and navigation
There are external means of propulsion such as magnetic fields, electric fields, or ultrasonic waves. Example: A study published in Magnetically-powered nanorobots enhance drug uptake in tumors used robots with metal emitters that could rotate within the magnetic field to propel them through the cell membrane. There are also self-propulsion methods based on chemical reactions or nanometer-scale motors.
2.1 Materials and Structure
Nanobots are often made of biocompatible materials such as gold, nickel, polymers, or nanostructures such as “DNA origami.”The materials must be biocompatible and not cause harmful immune responses.
Definition and concept
Nanobots are extremely small robots or devices (nanometer or micrometer scale) designed to perform precise tasks inside the human body, often at the cellular or tissue level.For example, the article “Autonomous Nanorobots as Miniaturized Surgeons for Intracellular Applications” explained that these robots can overcome cellular barriers, enter cells, and interact directly with them. On the other hand, a comprehensive review entitled “Nanorobots in Medicine: Advancing Healthcare through Molecular Engineering” published in November 2024 is a recent reference on the concept.
2.4 Work cycle inside the body
In the case of injectable drug delivery, the term “CTPIRT” (Circulation → Targeting → Penetration → Internalization → Release → Treatment) is used to describe the stages that nanorobots go through when treating a tumor.
For example: distribution in the bloodstream, targeting to the site, entry into the tissue, drug release, and therapeutic effect.
2.1 Materials and Structure
Nanobots are often made of biocompatible materials such as gold, nickel, polymers, or nanostructures such as “DNA origami.”The materials must be biocompatible and not cause harmful immune responses.
2.3 Targeting and payload delivery
Nanobots are equipped with sensors or ligands to bind to target cells, such as cancer cells. Delivery mechanisms depend on the local environment: tumor acidity (low pH), enzymes, or local heat.
medical application
3.1 Targeted drug delivery
One of the most prominent uses is delivering drugs directly to the tumor to reduce side effects and improve efficacy.
A recent example: robots made of nickel-coated gold spikes that respond to a magnetic field, helping to penetrate the cancer cell membrane and increase doxorubicin absorption.
3.2 Diagnostics & Monitoring
Nanobots can act as sensors inside the body that detect biomarkers such as proteins or ions before symptoms of disease appear. They also allow direct monitoring of the location of the disease or subtle changes at the cellular level.
3.3 Intracellular Surgery
A research paper titled “Autonomous Nanorobots as Miniaturized Surgeons for Intracellular Applications” shows that nanorobots can enter cells and interact with organelles such as mitochondria or proteins.
3.4 Other Applications: Cardiovascular, Nervous System, Eyes
Some studies suggest that nanorobots could be used in diseases of the nervous system or blood vessels, but this research is still in its early stages.
Challenges and Obstacles
4.1 Biosafety and Biocompatibility
How can we ensure that nanorobots do not cause an immune response or accumulate in tissues and cause long-term toxicity?
Also, what happens to the robot after it has completed its task? Is it discarded, decomposed, or stored?
4.2 Movement and navigation within the biological environment
Blood, biological fluids, and tissues are very complex environments for precise movement. Blood flow resistance, cellular complexities, aggregation, and dispersion all present challenges.
4.3 Scalable manufacturing and costs
Manufacturing micro-nanorobots in large quantities and with consistent quality is costly and technically complex.
4.4 Control and Tracking
How do you track the location of a nanorobot inside the body? How do you guide it with precision? How do you deal with error or malfunction?
4.5 Translation to the Clinic and Regulation
Regulations and regulations for nanorobots (as medical devices) are still incomplete. Safety procedures and human trials are needed.
Market and economic trends
A report by Mordor Intelligence shows that the nanorobotics market in healthcare is estimated at $7.25 billion in 2025 and is expected to reach $14.22 billion by 2030, with an annual growth rate of ~14.42%.
Another report by ResearchAndMarkets estimates the market at $7.8 billion in 2024 and $11 billion by 2030.
Future trends
Integration of artificial intelligence (AI) and machine learning with nanorobots to improve autonomous navigation and algorithms
Improving large-scale manufacturing, biodegradable materials, and low cost.
Improving the ability to access difficult areas such as the blood-brain barrier (BBB) or hard-to-reach tissues.
Focus on clinical trials and how to integrate this technology into medical practice.
Consideration of ethical considerations: privacy, equitable access, consent, unintended risks.
Conclusion
Nanobots truly represent a potential revolution in medicine: from early diagnosis to precise drug delivery, and even internal surgery at the cellular level. But the reality is that the road to widespread application is still long: there are technical, biological, regulatory, and even economic challenges. If these are overcome, we could see a real transformation in how diseases are treated, making this one of the most promising areas in technological medicine.